[1]
|
Borregaard, N. (2010) Neutrophils, from marrow to microbes. Immunity, 33, 657-670. http://dx.doi.org/10.1016/j.immuni.2010.11.011
|
[2]
|
Kumar, V. and Sharma, A. (2010) Neutrophils: Cinderella of innate immune system. International Immunopharmacology, 10, 1325-1334. http://dx.doi.org/10.1016/j.intimp.2010.08.012
|
[3]
|
Gerard, C. and Rollins, B.J. (2001) Chemokines and disease. Nature Immunology, 2, 108-115. http://dx.doi.org/10.1038/84209
|
[4]
|
Chintakuntlawar, A.V. and Chodosh, J. (2009) Chemokine CXCL1/KC and its receptor CXCR2 are responsible for neutrophil chemotaxis in adenoviral keratitis. Journal of Interferon & Cytokine Research, 29, 657-666. http://dx.doi.org/10.1089/jir.2009.0006
|
[5]
|
Jang, J.E., Hod, E.A., Spitalnik, S.L. and Frenette, P.S. (2011) CXCL1 and its receptor, CXCR2, mediate murine sickle cell vaso-occlusion during hemolytic transfusion reactions. Journal of Clinical Investigation, 121, 1397-1401. http://dx.doi.org/10.1172/JCI45336
|
[6]
|
Nagarkar, D.R., Wang, Q., Shim, J., Zhao, Y., Tsai, W.C., Lukacs, N.W., et al. (2009) CXCR2 is required for neutrophilic airway inflammation and hyperresponsiveness in a mouse model of human rhinovirus infection. Journal of Immunology, 183, 6698-6707. http://dx.doi.org/10.4049/jimmunol.0900298
|
[7]
|
Jacobs, J.P., Ortiz-Lopez, A., Campbell, J.J., Gerard, C.J., Mathis, D. and Benoist, C. (2010) Deficiency of CXCR2, but not other chemokine receptors, attenuates autoantibody-mediated arthritis in a murine model. Arthritis & Rheumatism, 62, 1921-1932.
|
[8]
|
Semple, B.D., Bye, N., Ziebell, J.M. and Morganti-Kossmann, M.C. (2010) Deficiency of the chemokine receptor CXCR2 attenuates neutrophil infiltration and cortical damage following closed head injury. Neurobiology of Disease, 40, 394-403. http://dx.doi.org/10.1016/j.nbd.2010.06.015
|
[9]
|
Wang, H., Tao, X.A., Xiang, J., Xia, J., Huang, Y. and Cheng, B. (2011) Neutrophils infiltration is early event of an oral mucosal xenotransplantation model. Medicina oral, Patología Oral y Cirugía Bucal, 16, e341-e347. http://dx.doi.org/10.4317/medoral.16.e341
|
[10]
|
Tao, X., Huang, Y., Li, R., Qing, R., Ma, L. and Rhodus, N.L. (2007) Assessment of local angiogenesis and vascular endothelial growth factor in the patients with atrophic-erosive and reticular oral lichen planus. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 103, 661-669. http://dx.doi.org/10.1016/j.tripleo.2006.05.023
|
[11]
|
Mackay, C.R. (2001) Chemokines: Immunology’s high impact factors. Nature Immunology, 2, 95-101. http://dx.doi.org/10.1038/84298
|
[12]
|
Kobayashi, Y. (2008)The role of chemokines in neutrophil biology. Frontiers in Bioscience, 13, 2400-2407. http://dx.doi.org/10.2741/2853
|
[13]
|
Mackay, C.R. (2008) Moving targets: cell migration inhibitors as new anti-inflammatory therapies. Nature Immunology, 9, 988-998. http://dx.doi.org/10.1038/ni.f.210
|
[14]
|
McLean, M.H., Murray, G.I., Stewart, K.N., Norrie, G., Mayer, C., Hold, G.L., et al. (2011) The inflammatory microenvironment in colorectal neoplasia. PLoS One, 6, e15366. http://dx.doi.org/10.1371/journal.pone.0015366
|
[15]
|
Segal, A.W. (2005) How neutrophils kill microbes. Annual Review of Immunology, 23, 197-223. http://dx.doi.org/10.1146/annurev.immunol.23.021704.115653
|
[16]
|
Lau, D. and Baldus, S. (2006) Myeloperoxidase and its contributory role in inflammatory vascular disease. Pharmacology & Therapeutics, 111, 16-26. http://dx.doi.org/10.1016/j.pharmthera.2005.06.023
|
[17]
|
van der Veen, B.S., de Winther, M.P. and Heeringa, P. (2009) Myeloperoxidase: Molecular mechanisms of action and their relevance to human health and disease. Antioxidants & Redox Signaling, 11, 2899-937.
|
[18]
|
Loria, V., Dato, I., Graziani, F. and Biasucci, L.M. (2008) Myeloperoxidase: A new biomarker of inflammation in ischemic heart disease and acute coronary syndromes. Mediators of Inflammation, 2008, Article ID: 135625. http://dx.doi.org/10.1155/2008/135625
|
[19]
|
Nussbaum, G. and Shapira, L.J. (2011) How has neutronphil research improved our understanding of periodontal pathogenesis? Journal of Clinical Periodontology, 38, 49-59. http://dx.doi.org/10.1111/j.1600-051X.2010.01678.x
|
[20]
|
Houghton, A.M. (2010) The paradox of tumor-associated neutrophils: fueling tumor growth with cytotoxic substances. Cell Cycle, 9, 1732-1737. http://dx.doi.org/10.4161/cc.9.9.11297
|
[21]
|
Tazzyman, S., Lewis, C.E. and Murdoch, C. (2009) Neutrophils: Key mediators of tumour angiogenesis. International Journal of Experimental Pathology, 90, 222-231.
|
[22]
|
Gregory, A.D. and Houghton, A.M. (2011) Tumor-associated neutrophils: New targets for cancer therapy. Cancer Research, 71, 2411-2416. http://dx.doi.org/10.1158/0008-5472.CAN-10-2583
|
[23]
|
Pereira, R., Medeiros, Y.S. and Fröde, T.S. (2006) Antiinflammatory effects of Tacrolimus in a mouse model of pleurisy. Transplant Immunology, 16, 105-111. http://dx.doi.org/10.1016/j.trim.2006.04.001
|
[24]
|
Furuichi, Y., Noto, T., Li, J.Y., Oku, T., Ishiye, M. and Moriguchi, A. (2004) Multiple modes of action of tacrolimus (FK506) for neuroprotective action on ischemic damage after transient focal cerebral ischemia in rats. Brain Research, 1014, 120-130. http://dx.doi.org/10.1016/j.brainres.2004.04.031
|
[25]
|
Caproni, M., Torchia, D., Antiga, E., Terranova, M., Volpi, W., del Bianco, E., et al. (2007) The comparative effects of tacrolimus and hydrocortisone in adult atopic dermatitis: An immunohistochemical study. British Journal of Dermatology, 156, 312-319. http://dx.doi.org/10.1111/j.1365-2133.2006.07609.x
|
[26]
|
Koshika, T., Hirayama, Y., Ohkubo, Y., Mutoh, S. and Ishizaka, A. (2005) Tacrolimus (FK506) has protective actions against murine bleomycin-induced acute lung injuries. European Journal of Pharmacology, 515, 169-178. http://dx.doi.org/10.1016/j.ejphar.2005.03.042
|
[27]
|
van Lierop, P.P., de Haar, C., Lindenbergh-Kortleve, D.J., Simons-Oosterhuis, Y., van Rijt, L.S., Lambrecht, B.N., et al. (2010) T-cell regulation of neutrophil infiltrate at the early stages of a murine colitis model. Inflammatory Bowel Diseases, 16, 442-451. http://dx.doi.org/10.1002/ibd.21073
|